Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 06 Feb 2019
At a glance
- Drugs ZIKV IG (Primary)
- Indications Zika virus infection
- Focus Adverse reactions
- Sponsors Emergent BioSolutions
- 25 Jan 2019 Planned End Date changed from 1 Feb 2019 to 6 Mar 2019.
- 25 Jan 2019 Planned primary completion date changed from 1 Feb 2019 to 6 Mar 2019.
- 25 Jan 2019 Status changed from recruiting to active, no longer recruiting.